GB8903804D0 - Improvements in or relating to organic compounds - Google Patents
Improvements in or relating to organic compoundsInfo
- Publication number
- GB8903804D0 GB8903804D0 GB898903804A GB8903804A GB8903804D0 GB 8903804 D0 GB8903804 D0 GB 8903804D0 GB 898903804 A GB898903804 A GB 898903804A GB 8903804 A GB8903804 A GB 8903804A GB 8903804 D0 GB8903804 D0 GB 8903804D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- relating
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898903804A GB8903804D0 (en) | 1989-02-20 | 1989-02-20 | Improvements in or relating to organic compounds |
CH504/90A CH680650A5 (en) | 1989-02-20 | 1990-02-16 | |
GB9003616A GB2228198B (en) | 1989-02-20 | 1990-02-16 | Novel cyclosporin galenic forms |
JP2038168A JPH0611703B2 (en) | 1989-02-20 | 1990-02-19 | New cyclosporin formulation |
DE4005190A DE4005190A1 (en) | 1989-02-20 | 1990-02-19 | NEW CYCLOSPORINE GALENIC FORMS |
BE9000181A BE1005236A3 (en) | 1989-02-20 | 1990-02-19 | PHARMACEUTICAL COMPOSITIONS cyclosporin. |
FR9002086A FR2643262B1 (en) | 1989-02-20 | 1990-02-19 | PHARMACEUTICAL COMPOSITIONS BASED ON CYCLOSPORINS |
IT47650A IT1240765B (en) | 1989-02-20 | 1990-02-20 | CYCLOSPORINE PHARMACEUTICAL COMPOSITIONS. |
US08/163,193 US5639724A (en) | 1984-07-24 | 1993-12-06 | Cyclosporin galenic forms |
US08/471,301 US5759997A (en) | 1984-07-24 | 1995-06-06 | Cyclosporin galenic forms |
US08/471,302 US5652212A (en) | 1984-07-24 | 1995-06-06 | Cyclosporin galenic forms |
HK149595A HK149595A (en) | 1989-02-20 | 1995-09-21 | Novel cyclosporin galenic forms |
SA95160491A SA95160491B1 (en) | 1989-02-20 | 1995-12-31 | New galenic forms of cyclosporin |
CY188696A CY1886A (en) | 1989-02-20 | 1996-04-05 | Novel cyclosporin galenic forms |
US09/047,056 US5977066A (en) | 1984-07-24 | 1998-03-24 | Cyclosporin galenic forms |
US09/552,634 US6306825B1 (en) | 1984-07-24 | 2000-04-19 | Cyclosporin galenic forms |
US09/931,680 US6468968B2 (en) | 1984-07-24 | 2001-08-16 | Cyclosporin galenic forms |
US10/234,273 US20030060402A1 (en) | 1984-07-24 | 2002-09-04 | Novel cyclosporin galenic forms |
US10/790,543 US7081445B2 (en) | 1989-02-20 | 2004-03-01 | Cyclosporin galenic forms |
US11/453,504 US7511014B2 (en) | 1989-02-20 | 2006-06-15 | Cyclosporin galenic forms |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898903804A GB8903804D0 (en) | 1989-02-20 | 1989-02-20 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8903804D0 true GB8903804D0 (en) | 1989-04-05 |
Family
ID=10651981
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB898903804A Pending GB8903804D0 (en) | 1984-07-24 | 1989-02-20 | Improvements in or relating to organic compounds |
GB9003616A Expired - Lifetime GB2228198B (en) | 1989-02-20 | 1990-02-16 | Novel cyclosporin galenic forms |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9003616A Expired - Lifetime GB2228198B (en) | 1989-02-20 | 1990-02-16 | Novel cyclosporin galenic forms |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPH0611703B2 (en) |
BE (1) | BE1005236A3 (en) |
CH (1) | CH680650A5 (en) |
CY (1) | CY1886A (en) |
DE (1) | DE4005190A1 (en) |
FR (1) | FR2643262B1 (en) |
GB (2) | GB8903804D0 (en) |
HK (1) | HK149595A (en) |
IT (1) | IT1240765B (en) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
HU208491B (en) * | 1990-11-27 | 1993-11-29 | Gyogyszerkutato Intezet | Process for producing oral pharmaceutical composition containing cyclosporin |
IL102236A0 (en) * | 1991-06-27 | 1993-01-14 | Ltt Inst Co Ltd | Topical preparations containing cyclosporin |
GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
AU688920B2 (en) * | 1991-06-27 | 1998-03-19 | Novartis Ag | Transesterified corn oil products |
DE69307505T2 (en) | 1992-05-13 | 1997-07-24 | Sandoz Ag | OPTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN |
US5759566A (en) * | 1992-07-28 | 1998-06-02 | Poli Industria Chimica Spa | Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents |
DK0589843T3 (en) | 1992-09-25 | 2002-04-02 | Novartis Ag | Cyclosporin-containing pharmaceutical preparations |
ATE218878T1 (en) † | 1993-04-20 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | NEW PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING CYCLOSPORINE |
DE4412201A1 (en) * | 1993-04-20 | 1994-11-10 | Rentschler Arzneimittel | New pharmaceutical preparations for oral administration containing cyclosporin |
NZ247516A (en) * | 1993-04-28 | 1995-02-24 | Bernard Charles Sherman | Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant |
DE4322826A1 (en) * | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmaceutical preparation |
DE4340781C3 (en) * | 1993-11-30 | 2000-01-27 | Novartis Ag | Liquid preparations containing cyclosporin and process for their preparation |
US5891846A (en) * | 1994-02-17 | 1999-04-06 | Shiseido Company, Ltd. | Cyclosporin-containing emulsion composition |
EP0694308A4 (en) * | 1994-02-17 | 1997-09-10 | Shiseido Co Ltd | Cyclosporin-containing emulsion composition |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
PT789580E (en) | 1994-11-03 | 2002-09-30 | Novartis Ag | CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION |
US5603951A (en) * | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
KR0167613B1 (en) * | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | Cyclosporin-containing soft capsule compositions |
US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
US5766629A (en) * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
DE19544507B4 (en) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin containing preparations |
CZ288631B6 (en) * | 1996-01-18 | 2001-08-15 | Galena, A. S. | Therapeutic preparations containing cyclosporin |
US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
KR20000069900A (en) | 1997-01-30 | 2000-11-25 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | Oil-Free Pharmaceutical Compositions Containing Cyclosporin A |
WO1998040051A1 (en) * | 1997-03-12 | 1998-09-17 | Abbott Laboratories | Lipophilic binary systems for the administration of lipophilic compounds |
ATE286403T1 (en) * | 1997-03-12 | 2005-01-15 | Abbott Lab | HYDROPHILIC BINARY SYSTEMS FOR ADMINISTRATION OF CYCLOSPORINE |
BR9810729B1 (en) | 1997-07-29 | 2010-07-13 | pharmaceutical composition for acid lipophilic compounds arranged as a self-emulsifying formulation. | |
KR100509130B1 (en) * | 1997-07-29 | 2005-08-18 | 파마시아 앤드 업존 캄파니 엘엘씨 | Self-Emulsifying Formulation for Lipophilic Compounds |
US6008191A (en) * | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin |
US6187747B1 (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin |
US6346511B1 (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
ID25908A (en) * | 1998-03-06 | 2000-11-09 | Novartis Ag | EMULSION PRACTONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDES |
DE19859910C2 (en) * | 1998-12-23 | 2001-03-22 | Ratiopharm Gmbh | Oral medicine |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
GB9912476D0 (en) | 1999-05-28 | 1999-07-28 | Novartis Ag | Organic compounds |
GB2362573A (en) * | 2000-05-25 | 2001-11-28 | Cipla Ltd | Cyclosporin formulation |
WO2001032143A1 (en) * | 1999-11-02 | 2001-05-10 | Cipla Ltd. | A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof |
DK1151755T3 (en) * | 2000-05-04 | 2005-06-27 | Panacea Biotec Ltd | Pharmaceutical preparation containing cyclosporin as active ingredient |
DE10030378A1 (en) * | 2000-06-21 | 2002-03-14 | Audit Inst For Medical Service | New pharmaceutical composition for topical application of water-insoluble and / or poorly water-soluble active ingredients |
US6979672B2 (en) | 2002-12-20 | 2005-12-27 | Polichem, S.A. | Cyclosporin-based pharmaceutical compositions |
JP4381037B2 (en) | 2003-06-04 | 2009-12-09 | 花王株式会社 | Oil composition |
CN101141953A (en) * | 2005-03-21 | 2008-03-12 | 伊瓦克斯制药有限公司 | Crystallization inhibitor and its use in gelatin capsules |
KR20080009201A (en) | 2005-04-15 | 2008-01-25 | 클라루스 쎄러퓨틱스, 아이엔씨. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
FR2914188B1 (en) * | 2007-03-28 | 2012-06-22 | Trophos | NEW CHOLEST-4-EN-3-ONE OXIME COMPOSITION |
GB2451811A (en) | 2007-08-09 | 2009-02-18 | Ems Sa | Delivery composition for solubilising water-insoluble pharmaceutical active ingredients |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
CA2690490C (en) * | 2010-01-19 | 2012-06-26 | Accucaps Industries Limited | Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
WO2015108045A1 (en) * | 2014-01-16 | 2015-07-23 | マルホ株式会社 | Topical agent for transdermal administration |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
EP3952899A1 (en) * | 2019-04-11 | 2022-02-16 | R.P. Scherer Technologies, LLC | Formulation for oral delivery of proteins, peptides and small molecules with poor permeability |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI65914C (en) * | 1978-03-07 | 1984-08-10 | Sandoz Ag | FRAMEWORK FOR PHARMACEUTICAL COMPOSITION OF CYCLOSPORINE A |
CH641356A5 (en) * | 1979-02-27 | 1984-02-29 | Sandoz Ag | Pharmaceutical compositions containing cyclosporin |
BE895724A (en) * | 1982-02-01 | 1983-07-28 | Sandoz Sa | NEW THERAPEUTIC USE OF DIHYDROCYCLOSPORIN D |
-
1989
- 1989-02-20 GB GB898903804A patent/GB8903804D0/en active Pending
-
1990
- 1990-02-16 CH CH504/90A patent/CH680650A5/de not_active IP Right Cessation
- 1990-02-16 GB GB9003616A patent/GB2228198B/en not_active Expired - Lifetime
- 1990-02-19 DE DE4005190A patent/DE4005190A1/en not_active Ceased
- 1990-02-19 BE BE9000181A patent/BE1005236A3/en not_active IP Right Cessation
- 1990-02-19 FR FR9002086A patent/FR2643262B1/en not_active Expired - Lifetime
- 1990-02-19 JP JP2038168A patent/JPH0611703B2/en not_active Expired - Lifetime
- 1990-02-20 IT IT47650A patent/IT1240765B/en active IP Right Grant
-
1995
- 1995-09-21 HK HK149595A patent/HK149595A/en not_active IP Right Cessation
-
1996
- 1996-04-05 CY CY188696A patent/CY1886A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB2228198A (en) | 1990-08-22 |
BE1005236A3 (en) | 1993-06-08 |
IT1240765B (en) | 1993-12-17 |
CH680650A5 (en) | 1992-10-15 |
JPH02255623A (en) | 1990-10-16 |
HK149595A (en) | 1995-09-29 |
GB9003616D0 (en) | 1990-04-11 |
FR2643262B1 (en) | 1993-06-11 |
GB2228198B (en) | 1992-12-16 |
IT9047650A0 (en) | 1990-02-20 |
JPH0611703B2 (en) | 1994-02-16 |
IT9047650A1 (en) | 1990-08-21 |
FR2643262A1 (en) | 1990-08-24 |
DE4005190A1 (en) | 1990-08-23 |
CY1886A (en) | 1996-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8903804D0 (en) | Improvements in or relating to organic compounds | |
AP9000217A0 (en) | Improvements in or relating to organic compounds | |
GB8901517D0 (en) | Improvements in or relating to organic compounds | |
AP9000207A0 (en) | Improvements in or relating to organic compounds | |
GB8900246D0 (en) | Improvements in or relating to organic compounds | |
GB8900455D0 (en) | Improvements in or relating to organic compounds | |
GB8900847D0 (en) | Improvements in or relating to organic compounds | |
GB8902154D0 (en) | Improvements in or relating to organic compounds | |
GB8902303D0 (en) | Improvements in or relating to organic compounds | |
GB8902304D0 (en) | Improvements in or relating to organic compounds | |
GB8902305D0 (en) | Improvements in or relating to organic compounds | |
GB8902656D0 (en) | Improvements in or relating to organic compounds | |
GB8902897D0 (en) | Improvements in or relating to organic compounds | |
GB8902898D0 (en) | Improvements in or relating to organic compounds | |
GB8902899D0 (en) | Improvements in or relating to organic compounds | |
GB8902900D0 (en) | Improvements in or relating to organic compounds | |
GB8902901D0 (en) | Improvements in or relating to organic compounds | |
GB8902902D0 (en) | Improvements in or relating to organic compounds | |
GB8902903D0 (en) | Improvements in or relating to organic compounds | |
GB8903146D0 (en) | Improvements in or relating to organic compounds | |
GB8903147D0 (en) | Improvements in or relating to organic compounds | |
GB8903149D0 (en) | Improvements in or relating to organic compounds | |
GB8903150D0 (en) | Improvements in or relating to organic compounds | |
GB8903151D0 (en) | Improvements in or relating to organic compounds | |
GB8903152D0 (en) | Improvements in or relating to organic compounds |